Abstract
A series of unique indazoles and pyridoindolones have been rationally designed and synthesized as novel classes of cannabinoid ligands based on a proposed bioactive amide conformation. This has led to the discovery of the novel indolopyridone 3a as a conformationally constrained cannabinoid ligand that displays high affinity for the CB2 receptor (K(i)(CB2) = 1.0 nM) and possesses antiinflammatory properties when administered orally in an in vivo murine inflammation model.
MeSH terms
-
Administration, Oral
-
Animals
-
Anti-Inflammatory Agents, Non-Steroidal / chemical synthesis*
-
Anti-Inflammatory Agents, Non-Steroidal / chemistry
-
Anti-Inflammatory Agents, Non-Steroidal / pharmacology
-
Cannabinoids / metabolism*
-
Cells, Cultured
-
Cricetinae
-
Drug Design
-
Female
-
Humans
-
Indoles / chemical synthesis*
-
Indoles / chemistry
-
Indoles / pharmacology
-
Inflammation / chemically induced
-
Inflammation / metabolism
-
Leukocytes, Mononuclear / metabolism
-
Ligands
-
Lipopolysaccharides
-
Mice
-
Mice, Inbred BALB C
-
Models, Molecular
-
Molecular Conformation
-
Norbornanes / chemical synthesis*
-
Norbornanes / chemistry
-
Norbornanes / pharmacology
-
Pyridones / chemical synthesis*
-
Pyridones / chemistry
-
Pyridones / pharmacology
-
Receptors, Cannabinoid
-
Receptors, Drug / agonists*
-
Structure-Activity Relationship
-
Tumor Necrosis Factor-alpha / metabolism
Substances
-
2,5-dihydro-6-methoxy-5-(2-(4-morpholinyl)ethyl)-2-(1,3,3-trimethylbicyclo(2.2.1)heptan-2-yl)-1H-pyrido(4,3-b)indol-1-one
-
Anti-Inflammatory Agents, Non-Steroidal
-
Cannabinoids
-
Indoles
-
Ligands
-
Lipopolysaccharides
-
Norbornanes
-
Pyridones
-
Receptors, Cannabinoid
-
Receptors, Drug
-
Tumor Necrosis Factor-alpha